Your browser doesn't support javascript.
loading
Adenosine signaling promotes hematopoietic stem and progenitor cell emergence.
Jing, Lili; Tamplin, Owen J; Chen, Michael J; Deng, Qing; Patterson, Shenia; Kim, Peter G; Durand, Ellen M; McNeil, Ashley; Green, Julie M; Matsuura, Shinobu; Ablain, Julien; Brandt, Margot K; Schlaeger, Thorsten M; Huttenlocher, Anna; Daley, George Q; Ravid, Katya; Zon, Leonard I.
Afiliação
  • Jing L; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Tamplin OJ; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Chen MJ; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Deng Q; Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706 Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706.
  • Patterson S; Department of Medicine, Boston University School of Medicine and the Evans Center for Interdisciplinary Biomedical Research, Boston, MA 02118.
  • Kim PG; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138 Harvard Stem C
  • Durand EM; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • McNeil A; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Green JM; Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706 Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706.
  • Matsuura S; Department of Medicine, Boston University School of Medicine and the Evans Center for Interdisciplinary Biomedical Research, Boston, MA 02118.
  • Ablain J; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Brandt MK; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Schlaeger TM; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
  • Huttenlocher A; Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706 Department of Medical Microbiology and Immunology and Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706.
  • Daley GQ; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138 Harvard Stem C
  • Ravid K; Department of Medicine, Boston University School of Medicine and the Evans Center for Interdisciplinary Biomedical Research, Boston, MA 02118.
  • Zon LI; Stem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115 Harvard Stem Cell Institute, Howard Hughes Medical Institute, and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138 Harvard Stem C
J Exp Med ; 212(5): 649-63, 2015 May 04.
Article em En | MEDLINE | ID: mdl-25870200
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aorta / Células-Tronco Hematopoéticas / Endotélio Vascular / Adenosina / Receptor A2B de Adenosina Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aorta / Células-Tronco Hematopoéticas / Endotélio Vascular / Adenosina / Receptor A2B de Adenosina Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2015 Tipo de documento: Article